"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
AMBENONIUM - ORAL
COMMON BRAND NAME(S): Mytelase
USES: Ambenonium is used to improve muscle strength in patients with a certain muscle disease (myasthenia gravis). It works by preventing the breakdown of a certain natural substance (acetylcholine) in your body. Acetylcholine is needed for normal muscle function.
HOW TO USE: Take this medication by mouth with or without food, usually 3 to 4 times daily or as directed by your doctor. Taking this medication with food or milk may help to decrease side effects.
Dosage is based on your medical condition and response to therapy. Talk with your doctor about how you respond to the medication and about when you feel the most tired or weak so that your doctor can make the proper dosage changes.
Do not increase your dose or take this medication more often than prescribed. Doing so may increase the risk of serious side effects.
Tell your doctor if your condition persists or worsens or if the medication stops working well.
Additional Mytelase Information
Report Problems to the Food and Drug Administration
Find out what women really need.